BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37586639)

  • 1. Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician.
    Sharma S; Fishbein L
    Endocr Pract; 2023 Dec; 29(12):999-1006. PubMed ID: 37586639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
    Hamidi O
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
    Meijs AC; Snel M; Corssmit EPM
    Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
    Lima JV; Kater CE
    Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.
    Goncalves J; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
    Ann Endocrinol (Paris); 2019 Jun; 80(3):159-162. PubMed ID: 31053249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
    Kuo MJM; Nazari MA; Jha A; Pacak K
    Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic paraganglioma.
    Lee JA; Duh QY
    World J Surg; 2008 May; 32(5):683-7. PubMed ID: 18224469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
    Jochmanová I; Lazúrová I
    Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytomas and Paragangliomas.
    Tevosian SG; Ghayee HK
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy.
    Clifton-Bligh RJ
    Rev Endocr Metab Disord; 2023 Feb; 24(1):49-56. PubMed ID: 36637675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
    Schreiner F; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary malignant tumors of the adrenal glands.
    Almeida MQ; Bezerra-Neto JE; Mendonça BB; Latronico AC; Fragoso MCBV
    Clinics (Sao Paulo); 2018 Dec; 73(suppl 1):e756s. PubMed ID: 30540124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
    Khatami F; Mohammadamoli M; Tavangar SM
    Endocr Regul; 2018 Jan; 52(1):41-54. PubMed ID: 29453919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
    De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
    J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.
    Talvacchio S; Nazari MA; Pacak K
    Curr Opin Endocrinol Diabetes Obes; 2022 Jun; 29(3):294-301. PubMed ID: 35621181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adrenal tumours in childhood].
    Martos-Moreno GA; Pozo-Román J; Argente J
    An Pediatr (Barc); 2013 Sep; 79(3):187.e1-187.e16. PubMed ID: 23796614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.
    Patel HV; Srivastava A; Becker MD; Beninato T; Laird AM; Singer EA
    Curr Urol Rep; 2021 Jan; 22(1):2. PubMed ID: 33403502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
    Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
    J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.